Prescribing Information for:KliovanceKliofemNovofemTrisequensVagifem

Prescribing Information for:KliovanceKliofem

NovofemTrisequensVagifem

Are you having HRT supply issues?

Novo Nordisk remain in stock for all products in the HRT range
and provide a reliable supply chain

Name Oestrogen/Progestagen Type In stock today
Kliovance®
oral tablets1
Estradiol 1 mg, norethisterone 0.5 mg
(white tablet)
Continuous combined
Kliofem®
oral tablets2
Estradiol 2 mg, norethisterone 1 mg
(white tablet)
Continuous combined
Novofem®
oral tablets3

Estradiol 1 mg
(red tablet)

Norethisterone 1 mg Estradiol 1 mg
(white tablet)

Sequential combined
Trisequens®
oral tablets4

Estradiol 2 mg
(blue tablet)

Estradiol 2 mg, norethisterone 1 mg
(white tablet)

Estradiol 1 mg
(red tablet)

Sequential combined
Vagifem®
vaginal tablet5
estradiol 10 ug
(white vaginal tablet)
Local
(vaginal)
More Information…

HRT Supply Issues

You may be aware of current supply issues with some Hormone Replacement Therapy (HRT) products.

Please be assured that these supply issues do not apply to the Novo Nordisk range of HRT products

The resources area on this site provides a convenient PDF document listing the Novo Nordisk HRT range, including composition, type and dosing of each product.

If you require further information, please contact Customer Care on 0845 600 5055 (calls may be monitored for training purposes).

NICE guidelines recommend:6

Systemic HRT should be offered after full consideration of benefits and risk for:

• Vasomotor symptoms e.g. hot flushes, sweats

• Psychological symptoms e.g. low mood

References:
1.Kliovance® Summary of Product Characteristics. 2. Kliofem® Summary of Product Characteristics. 3. Novofem® Summary of Product Characteristics. 4. Trisequens® Summary of Product Characteristics. 5. Vagifem® Summary of Product Characteristics. 6. NICE Guideline NG23 Menopause: diagnosis and management, November 2015.

This is a Novo Nordisk® website intended for UK healthcare professionals

Date of preparation: July 2020  UK20VG00009   Privacy Policy   Contact us

This is a Novo Nordisk® website intended for healthcare professionals

Date of preparation: July 2020
UK20VG00009
Privacy Policy   Contact us